Selected research
Industry Growth & Trends
Global Pre-Pregnancy Genetic Screening Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pre-Pregnancy Genetic Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pre-Pregnancy Genetic Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pre-Pregnancy Genetic Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pre-Pregnancy Genetic Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pre-Pregnancy Genetic Screening Service market include Invitae, Natera, Fulgent Genetics, Myriad Genetics, Quest Diagnostics, LabCorp, GeneDx, Vitrolife and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pre-Pregnancy Genetic Screening Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pre-Pregnancy Genetic Screening Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pre-Pregnancy Genetic Screening Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pre-Pregnancy Genetic Screening Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pre-Pregnancy Genetic Screening Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pre-Pregnancy Genetic Screening Service Market by Company
Invitae
Natera
Fulgent Genetics
Myriad Genetics
Quest Diagnostics
LabCorp
GeneDx
Vitrolife
Illumina
BillionToOne
Juno Genetics
MedGenome
23andMe
Sonic Genetics
CEN4GEN
BGI Genomics
Berry Genomics
Anoroad
KingMed Diagnostics
CapitalBio Technology
Pre-Pregnancy Genetic Screening Service Segment by Type
Single Disease Screening
Whole Genome Screening
Pre-Pregnancy Genetic Screening Service Segment by Application
Medical and Health Institutions
Research and Educational Institutions
Others
Pre-Pregnancy Genetic Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Pregnancy Genetic Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-Pregnancy Genetic Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Pregnancy Genetic Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pre-Pregnancy Genetic Screening Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Single Disease Screening
- Whole Genome Screening
Applications
- Medical and Health Institutions
- Research and Educational Institutions
- Others
Companies covered
- Invitae
- Natera
- Fulgent Genetics
- Myriad Genetics
- Quest Diagnostics
- LabCorp
- GeneDx
- Vitrolife
- Illumina
- BillionToOne
- Juno Genetics
- MedGenome
- 23andMe
- Sonic Genetics
- CEN4GEN
- BGI Genomics
- Berry Genomics
- Anoroad
- KingMed Diagnostics
- CapitalBio Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pre-Pregnancy Genetic Screening Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pre-Pregnancy Genetic Screening Service Market Size by Region (2021-2032)
- 1.4.1 Global Pre-Pregnancy Genetic Screening Service Market Size by Region (2021-2026)
- 1.4.2 Global Pre-Pregnancy Genetic Screening Service Market Size by Region (2027-2032)
- 1.5 Key Regions Pre-Pregnancy Genetic Screening Service Market Size (2021-2032)
- 1.5.1 North America Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (2021-2032)
2 Pre-Pregnancy Genetic Screening Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Single Disease Screening
- 2.1.2 Whole Genome Screening
- 2.2 Global Pre-Pregnancy Genetic Screening Service Market Size by Type
- 2.2.1 Global Pre-Pregnancy Genetic Screening Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pre-Pregnancy Genetic Screening Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pre-Pregnancy Genetic Screening Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pre-Pregnancy Genetic Screening Service Market Size by Regions
- 2.3.1 North America Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Type (2021-2026)
3 Pre-Pregnancy Genetic Screening Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical and Health Institutions
- 3.1.2 Research and Educational Institutions
- 3.1.3 Others
- 3.2 Global Pre-Pregnancy Genetic Screening Service Market Size by Application
- 3.2.1 Global Pre-Pregnancy Genetic Screening Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pre-Pregnancy Genetic Screening Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pre-Pregnancy Genetic Screening Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pre-Pregnancy Genetic Screening Service Market Size by Regions
- 3.3.1 North America Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pre-Pregnancy Genetic Screening Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pre-Pregnancy Genetic Screening Service Industry Trends
- 4.2 Pre-Pregnancy Genetic Screening Service Industry Drivers
- 4.3 Pre-Pregnancy Genetic Screening Service Industry Opportunities and Challenges
- 4.4 Pre-Pregnancy Genetic Screening Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pre-Pregnancy Genetic Screening Service Revenue (2021-2026)
- 5.2 Global Pre-Pregnancy Genetic Screening Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pre-Pregnancy Genetic Screening Service Key Company Headquarters & Area Served
- 5.4 Global Pre-Pregnancy Genetic Screening Service Company, Product Type & Application
- 5.5 Global Pre-Pregnancy Genetic Screening Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pre-Pregnancy Genetic Screening Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pre-Pregnancy Genetic Screening Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Pre-Pregnancy Genetic Screening Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Invitae
- 6.1.1 Invitae Company Information
- 6.1.2 Invitae Business Overview
- 6.1.3 Invitae Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Invitae Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.1.5 Invitae Recent Developments
- 6.2 Natera
- 6.2.1 Natera Company Information
- 6.2.2 Natera Business Overview
- 6.2.3 Natera Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Natera Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.2.5 Natera Recent Developments
- 6.3 Fulgent Genetics
- 6.3.1 Fulgent Genetics Company Information
- 6.3.2 Fulgent Genetics Business Overview
- 6.3.3 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.3.5 Fulgent Genetics Recent Developments
- 6.4 Myriad Genetics
- 6.4.1 Myriad Genetics Company Information
- 6.4.2 Myriad Genetics Business Overview
- 6.4.3 Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Myriad Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.4.5 Myriad Genetics Recent Developments
- 6.5 Quest Diagnostics
- 6.5.1 Quest Diagnostics Company Information
- 6.5.2 Quest Diagnostics Business Overview
- 6.5.3 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.5.5 Quest Diagnostics Recent Developments
- 6.6 LabCorp
- 6.6.1 LabCorp Company Information
- 6.6.2 LabCorp Business Overview
- 6.6.3 LabCorp Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 LabCorp Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.6.5 LabCorp Recent Developments
- 6.7 GeneDx
- 6.7.1 GeneDx Company Information
- 6.7.2 GeneDx Business Overview
- 6.7.3 GeneDx Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GeneDx Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.7.5 GeneDx Recent Developments
- 6.8 Vitrolife
- 6.8.1 Vitrolife Company Information
- 6.8.2 Vitrolife Business Overview
- 6.8.3 Vitrolife Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Vitrolife Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.8.5 Vitrolife Recent Developments
- 6.9 Illumina
- 6.9.1 Illumina Company Information
- 6.9.2 Illumina Business Overview
- 6.9.3 Illumina Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Illumina Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.9.5 Illumina Recent Developments
- 6.10 BillionToOne
- 6.10.1 BillionToOne Company Information
- 6.10.2 BillionToOne Business Overview
- 6.10.3 BillionToOne Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 BillionToOne Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.10.5 BillionToOne Recent Developments
- 6.11 Juno Genetics
- 6.11.1 Juno Genetics Company Information
- 6.11.2 Juno Genetics Business Overview
- 6.11.3 Juno Genetics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Juno Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.11.5 Juno Genetics Recent Developments
- 6.12 MedGenome
- 6.12.1 MedGenome Company Information
- 6.12.2 MedGenome Business Overview
- 6.12.3 MedGenome Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 MedGenome Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.12.5 MedGenome Recent Developments
- 6.13 23andMe
- 6.13.1 23andMe Company Information
- 6.13.2 23andMe Business Overview
- 6.13.3 23andMe Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 23andMe Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.13.5 23andMe Recent Developments
- 6.14 Sonic Genetics
- 6.14.1 Sonic Genetics Company Information
- 6.14.2 Sonic Genetics Business Overview
- 6.14.3 Sonic Genetics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Sonic Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.14.5 Sonic Genetics Recent Developments
- 6.15 CEN4GEN
- 6.15.1 CEN4GEN Company Information
- 6.15.2 CEN4GEN Business Overview
- 6.15.3 CEN4GEN Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 CEN4GEN Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.15.5 CEN4GEN Recent Developments
- 6.16 BGI Genomics
- 6.16.1 BGI Genomics Company Information
- 6.16.2 BGI Genomics Business Overview
- 6.16.3 BGI Genomics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 BGI Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.16.5 BGI Genomics Recent Developments
- 6.17 Berry Genomics
- 6.17.1 Berry Genomics Company Information
- 6.17.2 Berry Genomics Business Overview
- 6.17.3 Berry Genomics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Berry Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.17.5 Berry Genomics Recent Developments
- 6.18 Anoroad
- 6.18.1 Anoroad Company Information
- 6.18.2 Anoroad Business Overview
- 6.18.3 Anoroad Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Anoroad Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.18.5 Anoroad Recent Developments
- 6.19 KingMed Diagnostics
- 6.19.1 KingMed Diagnostics Company Information
- 6.19.2 KingMed Diagnostics Business Overview
- 6.19.3 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.19.5 KingMed Diagnostics Recent Developments
- 6.20 CapitalBio Technology
- 6.20.1 CapitalBio Technology Company Information
- 6.20.2 CapitalBio Technology Business Overview
- 6.20.3 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Product Portfolio
- 6.20.5 CapitalBio Technology Recent Developments
7 North America
- 7.1 North America Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 7.3 North America Pre-Pregnancy Genetic Screening Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 8.3 Europe Pre-Pregnancy Genetic Screening Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pre-Pregnancy Genetic Screening Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 10.3 South America Pre-Pregnancy Genetic Screening Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pre-Pregnancy Genetic Screening Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst